Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2014 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Begins Human Abuse Liability Studies for ELI-200

NORTHVALE, N.J., June 9, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced dosing of the first subject in the treatment phase for a human...